Affimed (NASDAQ:AFMD) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on AFMD. Wells Fargo & Company reiterated an “equal weight” rating and set a $0.10 price […]
StockNews.com assumed coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on AFMD. Wells Fargo & Company reiterated an “equal weight” rating and set a $0.10 price […]
